| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 8 |
| 1 | DEXAMETHASONE 1.5 MG | 8 |
| 2 | IXAZOMIB | 8 |
| 3 | LENALIDOMIDE | 8 |
| 4 | BEVACIZUMAB | 6 |
| 5 | OXALIPLATIN | 6 |
| 6 | ASPIRIN | 3 |
| 7 | ASPIRIN 325 MG | 3 |
| 8 | ASPIRIN 81 MG | 3 |
| 9 | FLUOROURACIL | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 1 | RIVASTIGMINE TARTRATE | 1 | 0.0022 |
| 2 | MARALIXIBAT CHLORIDE | 1 | 0.0010 |
| 3 | PSYLLIUM HUSK | 1 | 0.0007 |
| 4 | LEVOLEUCOVORIN | 2 | 0.0005 |
| 5 | VELAGLUCERASE ALFA | 1 | 0.0005 |
| 6 | THIOGUANINE | 1 | 0.0005 |
| 7 | IXAZOMIB | 8 | 0.0003 |
| 8 | TEMSIROLIMUS | 1 | 0.0002 |
| 9 | ETODOLAC | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Stimulant Laxative [EPC] | 2 | 0.0001 |
| 1 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | Sigma-1 Agonist [EPC] | 1 | 0.0001 |
| 3 | Bile Acid [EPC] | 1 | 0.0000 |
| 4 | Epidermal Growth Factor Receptor Antagonist [EPC] | 2 | 0.0000 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 7 | 0.0000 |
| 6 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 6 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 6 | 0.0000 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |